Men's Formula Tablets

Natural health product licensed in Canada

Licence holder: BioV Pharma Inc.
NPN or DIN-HM: 80068115
Status: Inactive licence
Licence date: 30 March 2016
Revision date: Not provided
Form: Comprimé
Route of administration: Orale
Application type: Officinale

If this product were sold in France

Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Conditions légales
Prunus africana (Hook. f.) Kalkman: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Avena sativa Source : Fruit Hull	75 milligramme	Not calculated
Tribulus terrestris Source : Racine	25 milligramme	Not calculated
Astragalus membranaceus Source : Racine	10 milligramme	Not calculated
Urtica dioica Source : Feuille	37.5 milligramme	Not calculated
Prunus africana Source : Écorce (tige)	250 milligramme	Not calculated
Lepidium meyenii Source : Racine	150 milligramme	Not calculated
Epimedium brevicornu Source : Feuille	100 milligramme	Not calculated
Panax ginseng Source : Racine	50 milligramme	Not calculated
L-arginine Source : L-arginine	50 milligramme	Not calculated
Capsicum annuum Source : Fruit	25 milligramme	Not calculated
Crassostrea gigas Source : Shell	25 milligramme	Not calculated
Smilax glabra Source : Rhizome	12.5 milligramme	Not calculated
Glycyrrhiza glabra Source : Racine	10 milligramme	Not calculated
Cucurbita pepo Source : Cucurbita pepo - Graine	5 milligramme	Not calculated

Non-medicinal ingredients

Stéarate de magnésium, Dioxyde de silicium, Maltodextrine

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	Not specified	1 Comprimé	1 Tous les jours

Uses authorised in Canada

Used in Herbal Medicine to help relieve inflammatory conditions of the gastrointestinal tract, such as gastritis in adult. Used in Herbal Medicine to help maintain a healthy immune system. Traditionally used in Ayurveda as Vrsya (aphrodisiac) for men. L-Arginine is a non-essential amino acid that is involved in protein synthesis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have a liver disorder. Consult a health care practitioner prior to use if you have an auto-immune disorder. In case of qi or blood deficiency, consult a health care practitioner prior to us. Consult a health care practitioner prior to use if you have diabetes.
Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use. Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use.
Contre-indications
Do not use if you are taking thiazide diuretics, cardiac glycosides, corticosteroids, stimulant laxatives or other medications which may aggravate electrolyte imbalance. Do not use if you have hypokalemia, high blood pressure, or a kidney or cardiovascular disorder. If you have hypotension, do not use this product.

Source

Official Health Canada record, licence 80068115

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.